Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

F Skoulidis, JV Heymach - Nature Reviews Cancer, 2019 - nature.com
The impressive clinical activity of small-molecule receptor tyrosine kinase inhibitors for
oncogene-addicted subgroups of non-small-cell lung cancer (for example, those driven by …
被引用次数：746 相关文章

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy.

F Skoulidis, JV Heymach - Nature reviews. Cancer, 2019 - europepmc.org
The impressive clinical activity of small molecule receptor tyrosine kinase inhibitors (TKIs) for
oncogene-addicted subgroups of non-small cell lung cancer (NSCLC)[for example those …

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

F Skoulidis, JV Heymach - Nature Reviews Cancer, 2019 - mdanderson.elsevierpure.com
The impressive clinical activity of small-molecule receptor tyrosine kinase inhibitors for
oncogene-addicted subgroups of non-small-cell lung cancer (for example, those driven by …

[引用][C] Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

F Skoulidis, JV Heymach - Nature Reviews Cancer, 2019 - cir.nii.ac.jp
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

F Skoulidis, JV Heymach - Nature Reviews Cancer, 2019 - go.gale.com
The impressive clinical activity of small-molecule receptor tyrosine kinase inhibitors for
oncogene-addicted subgroups of non-small-cell lung cancer (for example, those driven by …

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

F Skoulidis, JV Heymach - Nature reviews. Cancer, 2019 - pubmed.ncbi.nlm.nih.gov
The impressive clinical activity of small-molecule receptor tyrosine kinase inhibitors for
oncogene-addicted subgroups of non-small-cell lung cancer (for example, those driven by …
[HTML] nih.gov

[HTML][HTML] Co-occurring genomic alterations in non-small cell lung cancer biology and therapy

F Skoulidis, JV Heymach - Nature reviews. Cancer, 2019 - ncbi.nlm.nih.gov
The impressive clinical activity of small molecule receptor tyrosine kinase inhibitors (TKIs) for
oncogene-addicted subgroups of non-small cell lung cancer (NSCLC)[for example those …

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy.

F Skoulidis, JV Heymach - Nature reviews. Cancer, 2019 - europepmc.org
The impressive clinical activity of small molecule receptor tyrosine kinase inhibitors (TKIs) for
oncogene-addicted subgroups of non-small cell lung cancer (NSCLC)[for example those …